Navigation Links
Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%
Date:2/21/2008

he US Patent No. 5,272,071. Serono's infringement suit against the Company in the Massachusetts's District Court was subsequently dismissed.
Full Year 2007 Unaudited Results

2007 2006

Non Non

US GAAP Adjustments GAAP(1) US GAAP Adjustments GAAP(1)

$M $M $M $M $M $M

_______ _________ __________ _______ __________ _______

Revenues 2,436.3 - 2,436.3 1,796.5 - 1,796.5

Operating

(loss)/income (1,379.1) 2,083.0 703.9 283.2 170.5 453.7

Net (1,451.8) 2,003.1 551.3 278.2 84.2 362.4

(loss)/income

Diluted

earnings per:

Ordinary (268.7c) 366.9c 98.2c 54.6c 16.4c 71.0c

share

ADS (806.1c) 1,100.7c 294.6c 163.8c 49.2c 213.0c

Q4 2007 Unaudited Results

Q4 2007 Q4 2006

Non Non

US GAAP Adjustments GAAP(1) US GAAP Adjustments GAAP(1)

$M $M $M $M $M $M

Revenues 724.5 - 724.5 497.0 - 497.0

Operating

income 232.2 (8.2) 224.0 80.4 34.7 115.1

Net income 212.1 (32.4) 179.7 68.6 27.0 95.6

Diluted

earnings

per:

Ordinary 36.9c (5.6c) 31.3c 13.4c 5.3c 18.7c

share

ADS 110.7c (16.8c) 93.9c 40.2c 15.9c 56.1c

Note: Average exchange rates for 2007 and 2006 were $2.00:GBP1.00 and $1.84:GBP1.00 respectively. Average exchange rates for Q4 <
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Shire plc: Correction Re Website
2. Shires ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
3. Shire Engages Palio
4. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
5. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
6. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
7. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
8. Shire plc: Board Changes
9. David Mott Appointed Non Executive Director at Shire
10. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
11. Shire Divests Non-Core Product Portfolio to Almirall
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 19, 2014 BioPlus Specialty Pharmacy ... announces the promotion of Nick Maroulis, Pharm.D. to the ... Services. , In this position, Dr. Maroulis will ... managing the directors of our multi-site pharmacies as the ... 1997 and during that time he has served in ...
(Date:12/19/2014)... , Dec. 19, 2014 Decision Resources ... will grow at a 12 percent compound annual growth ... of the aging population and the increasing adoption of ... America will also spur demand for dental ... dental implant and periodontal treatments. Other key ...
(Date:12/19/2014)... LayerBio is an MIT spin-off developing novel ... National Eye Institute (NEI) at the National Institutes of ... grant to develop a drug-eluting intraocular lens (IOL) for ... of vision loss in people over age 40 and ... Ken Mandell, LayerBio’s Founder and CEO, "There is a ...
(Date:12/19/2014)... In contrast to traditional LED lights where ... Valoya uses proprietary LED technology to incorporate their spectra ... which is critical in low proximity installations. The Valoya ... its lifetime which is up to four times longer ... investment cost was clearly higher when compared to traditional ...
Breaking Biology Technology:BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery 2
... Recommends ,Do Not Vote, For Any of ... Shareholders of Biovail,Corporation (NYSE: BVF )(TSX: BVF) said today ... sharply criticized the incumbent board and,recommended ,Do Not Vote, for ... vote FOR two of the Concerned Shareholders,nominees, Joseph J. Krivulka ...
... Germany is on the,cutting edge in biotechnology R&D ... Companies located in Germany are poised to,profit from the ... expert panel, at the BIO International Convention (BIO 2008),in ... co-chaired the,panel along with the CEO of a major ...
... Part Of Georgetown University Hospital Arsenal Against ... ... Sciences (OTC,Bulletin Board: DSCI), a provider of advanced wound care products,announced ... Leptospermum Honey, has been used by clinicians at Georgetown,University Hospital,s Wound ...
Cached Biology Technology:Biovail Concerned Shareholders Welcome Glass Lewis Evaluation 2Biovail Concerned Shareholders Welcome Glass Lewis Evaluation 3BIO 2008: Germany on Cutting Edge in Biomanufacturing 2Derma Sciences MEDIHONEY(TM) Helps to Save Patient's Limb 2Derma Sciences MEDIHONEY(TM) Helps to Save Patient's Limb 3Derma Sciences MEDIHONEY(TM) Helps to Save Patient's Limb 4
(Date:12/10/2014)... -- Valencell, a leader in performance biometric data sensor technology, ... its licensees for highly accurate, clinically validated biometric technology. ... from fitness and health sectors, but first responders/military and ... only as useful as the biometric data it delivers. ... long-term mass consumer adoption of wearable products," said Dr. ...
(Date:12/5/2014)... 2014 Increased emphasis on product quality, ... testing and inspection technologies. The convergence of industries ... range of innovative test solutions. This trend is ... which is generally more inclined towards communication, media ... strategies of test equipment vendors will cater to ...
(Date:11/21/2014)... November 18, 2014 According to ... by Systems (Video, RFID, Access Control, Intrusion Detection, Parking ... Banks, Government), Component Service Geography - Global Forecasts to ... is projected to be around $25 Billion in 2014 ... growing at a CAGR of 8.69%. Browse ...
Breaking Biology News(10 mins):Wearable Technology Products Demand Highly Accurate Biometric Technology 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
... to the national Centers for Disease Control and Prevention, 5 to ... with it. About 36,000 people will die. , But among health ... flu pandemic, such as a human strain of avian flu. And ... health crisis will come but when. Are we prepared? In a ...
... is believing, especially in medicine. From magnetic resonance ... of the body’s tissues and organs have become ... and make recommendations for effective treatment. ... Kent State University will provide doctors with a ...
... The skin’s ability to replace the tissue it sloughs off ... from Harvard Medical School published in the May 4 issue ... process not only for skin, but for many epithelial tissues ... epithelial stem cells turns out to be the p63 gene, ...
Cached Biology News:US control strategies may make flu epidemics worse, UCLA study shows 2Novel system developed to turn data into real-time, interactive 3-D images 2Master regulatory gene of epithelial stem cells identified 2
...
... Human CD66 acd Recognizes human ... neutrophils and cells in some cases ... with transfectants containing BGPa, NCA and ... Immunogen: Human ...
Request Info...
... GOAT ANTI-MOUSE IgG+IgA+IgM (H+L) ... with highly purified horseradish ... antibody has been absorbed ... fetal bovine, horse, goat, ...
Biology Products: